Cervical Cancer
Development of therapeutic nucleic acids is ongoing
Published in Gene Therapy Weekly, October 7th, 2004
"Cervical cancer is the second most common neoplastic disease affecting women worldwide. Basic, clinical, and epidemiological analyses indicate that expression of high-risk human papillomaviruses (HPVs) E6/E7 genes is the primary cause of cervical cancer and represent ideal targets for the application of therapeutic nucleic acids (TNAs)," wrote J.A. DiPaolo and colleagues.
According to the researchers, "Antisense oligodeoxyribonucleotides (AS-ODNs) and ribozymes (RZs) are the most effective TNAs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-10-07)
More Articles from Gene Therapy Weekly
- Breast Cancer
RNA inhibition counteracts the growth of human mammary tumor xenografts - Chemotherapy
Overexpressed dominant-negative FANCA helps cisplatin battle tumors - Gene Promoters
Tumor-specific gene therapy targets uterine cervical cancer - Gynecology
Suicide gene therapy makes ovarian cancer susceptible to chemotherapy - Oncology
Adenoviral p53 gene transfer and chemotherapy fight ovarian cancer cell growth - Adverse Drug Effects
Calbindin-D-28K protects renal tubular cells from cyclosporine toxicity - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
